RESUMO
BACKGROUND: The Parkinsonian syndromes (PS) belong to the frequent chronic neurological disorders that, due to their progressive character and complex therapeutic options, pose a large economic burden. MATERIAL AND METHODS: In a retrospective health economic study on the treatment of Parkinson's disease, various socioeconomic and clinical parameters were examined. In the years 2011-2012, a total of 29 patients with the diagnosis of a Parkinsonian syndrome who underwent an inpatient rehabilitation in the Department of Neurology of the Rehabilitation MediClin Center Bad Orb were recruited. For this group of patients, we calculated the direct treatment cost and also analyzed the treatment cost based on the German diagnosis-related groups (G-DRG, version 2012). RESULTS: The direct medical costs amounted to 113.47±13.10 per patient per day. Furthermore, cost simulation and comparison revealed significantly higher cost per day for those patients insured via the German statutory health insurance who undergo inpatient care service based on the DRG-based payment ( 241.77 vs. 171.74; p≤0.015). CONCLUSION: This study contributes to the achievement of transparency of the direct medical costs of Parkinson's disease treatment in the inpatient setting and emphasizes the cost differences compared to the G-DRG-based payment.
Assuntos
Custos de Cuidados de Saúde/estatística & dados numéricos , Hospitalização/economia , Programas Nacionais de Saúde/economia , Reabilitação Neurológica/economia , Transtornos Parkinsonianos/economia , Transtornos Parkinsonianos/reabilitação , Idoso , Feminino , Alemanha/epidemiologia , Gastos em Saúde/estatística & dados numéricos , Hospitalização/estatística & dados numéricos , Humanos , Pacientes Internados/estatística & dados numéricos , Masculino , Programas Nacionais de Saúde/estatística & dados numéricos , Reabilitação Neurológica/estatística & dados numéricos , Transtornos Parkinsonianos/epidemiologia , Prevalência , Fatores SocioeconômicosRESUMO
Parkinson syndromes (PS) represent frequent neurodegenerative disorders. The demographic change suggests an increasing prevalence of PS in the near future. Treatment expenses, early retirement and need of long-term care result in rising public health care expenditures. Standardised concepts of care do not only improve the quality of patient-centered care, but also help to minimize its consequential costs. Their implementation requires profound knowledge of therapeutic strategies and sociomedical regulations. Medical treatment and sociomedical care have to be regularly reevaluated and adapted to the patient's needs and disease severity. An optimal therapy concept guarantees the patient's long term social integration and improves the compliance.